Exogenous melatonin delays gastric emptying rate in rats: Role of CCK 2 and 5-HT3 receptors

Journal of Physiology and Pharmacology

Volumn 56, Issue 4, 2005, Pages 543-553

  Kasimay, O ^a   Cakir B ^a   Devseren, E ^a   Yegen, B C ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

5 HT 3; CCK; Gastric motility; Vagal afferent fibers

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; BRETYLIUM TOSYLATE; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; MELATONIN; PHENOLSULFONPHTHALEIN; RAMOSETRON; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SODIUM CHLORIDE;

ADRENERGIC TRANSMISSION; ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ARTICLE; CANNULA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INSTILLATION; EXPERIMENTAL DESIGN; MALE; NONHUMAN; RAT; SENSORY NERVE; STOMACH EMPTYING; STOMACH FISTULA; STOMACH MOTILITY; SYMPATHETIC BLOCKING; SYMPATHETIC GANGLION; SYMPATHETIC NERVE CELL; SYMPATHETIC TONE; VAGUS NERVE;

ADRENERGIC ANTAGONISTS; ANIMALS; AUTONOMIC NERVE BLOCK; BENZIMIDAZOLES; BENZODIAZEPINONES; BRETYLIUM TOSYLATE; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; GANGLIA, SYMPATHETIC; GASTRIC EMPTYING; GASTROINTESTINAL TRACT; MALE; MELATONIN; NEURONS, AFFERENT; PHENYLUREA COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS; VAGUS NERVE;

EID: 31144438616     PISSN: 08675910     EISSN: 08675910     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Reiter RJ. Pineal melatonin: Cell biology of its synthesis and physiological interactions. Endocrinol Rev 1991; 12: 151-180.
2. Zhdanova IV, Wurtman RJ, Lynch HJ, et al. Sleep-inducing effect of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 1995; 57: 552-558.
3. Poeggeler B, Reiter RJ, Tan D-X, Chen L-D, Manchester LC. Melatonin, hydroxyl-radical-mediated oxidative damage, and aging: a hypothesis. J Pineal Res 1993; 14: 151-168.
4. Pieri C, Marra M, Moroni F, Recchioni R, Marcheselli F. Melatonin: Peroxyl radical scavenger more effective than vitamin E. Life Sci 1994; 15: 271-276.
5. Reiter RJ. Melatonin: Lowering the high price of free radicals. News Physiol Sci 2000; 15: 246,250.
6. Motilva V, Cabeza J, Alarcon de la Lastra C. New issues about melatonin and its effects on the digestive system. Curre Pharm Des 2001; 7: 909-931.
7. Huether G. The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates. Experientia 1993; 49: 665-670.
8. Lee PN, Hong GX, Pang SF. Melatonin in the gastrointestinal tract. In Role of Melatonin and Pineal Peptides in Neuroimmunomodulation, Fraschini F, Reiter RJ (eds). New York, Plenum Press, 1991, pp. 1127-1136.
9. Bubenik GA. Localization, physiological significance and possible clinical implication of gastrointestinal melatonin. Biol Signals Recept 2001; 10: 350-366.
10. Zafar NP, Morgan E. Feeding entrains an endogenous rhythm of swimming activity in the blind Mexican cave fish. Proceedings, 8th Meeting of European Society on Chronobiology 1992; 165-166.
11. Roky R, Kapas L, Taishi P, Fang J, Krueger JM. Food distribution alters the diurnal distribution of sleep in rats. Physiol Behav 1999; 67: 697-703.
12. Krieger DT, Hauser H, Krey LC. Suprachiasmatic nucleus lesions do not abolish food-shifted circadian rhythmicity and temparature rhythmicity. Science 1977; 197: 398-402.
13. Bubenik GA, Pang Sf, Hacker RR, Smith TS. Melatonin concentrations in serum and tissues of porcine gastrointestinal tract and their relationship to the intake and passage of food. J Pineal Res 1996; 21: 251-256.
14. Aldhous M, Franey C, Wright J, Arend J. Plasma preparations of melatonin in man following oral absorption of different preparations. Br J Pharmac 1985; 19: 517-521.
15. Bubenik GA, Pang Sf. The role of serotonin and melatonin in tha gastrointestinal physiology: Ontogeny, regulation of food intake and mutual 5-HT, melatonin feedbacks. J Pineal Res 1994; 16: 91-99.
16. Shaji AV, Kulkarni SK. Evidence of gabaergic modulation in melatonin-induced short-term memory deficits and food consumption. Methods Find Exp Clin Pharmacol 1998; 20: 311-319.
17. Le Gouic S, Atgie C, Nibbelink M, et al. Effects of both a melatonin agonist and antagonist on seasonal changes in body mass and energy intake in the garden dormouse. Int J Obes 1996; 20: 661-667.
18. Ishibashi T, Hanh DW, Srivastava L, Kumaresan P, Turner CW. Effect of pinealectomy and melatonin on food consumption and thyroid hormone secretion rate. Proc Soc Exp Biol Med 1966; 122: 644-647.
19. Bermudez FF, Forbes JM, Indiji MH. Involvement of melatonin and thyroid hormones in the control of sleep, food intake and energy metabolism in the domestic fowl. J Physiol 1983; 337: 19-27.
20. Bartness TJ, Wade GN. Body weight, food intake and energy regulating in exercising and melatonin-treated Siberian Hamsters. Physiol Behav 1985; 35: 805-808.
21. Pinillos ML, De Pedro N, Alonso-Gomez AL, Alonso-Bedate M, Delgado MJ. Food intake inhibition by melatonin in goldfish (Carrassius auratus). Physiol Behav 2001; 72: 629-634.
22. Dark J, Rayha LL, Clarke-Lane I, Kimler V. Melatonin and lighting condition: absence of long-term effects on food intake and body weight regulation in the albino rat. Physiol Behav 1980; 25: 855-857.
23. Wolden-Hanson T, Mitton DR, McCants RL, et al. Daily melatonin administration to mild-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 2000; 141: 487-497.
24. Fioretti MC, Menconi E, Ricardi C. Study on the type of antiserotonergic antagonism exerted in vitro on rat's stomach by pineal indole derivatives. In Il Farmaco, Prat (eds), 1974, pp. 4101-4412.
25. Bubenik GA. The effect of serotonin, N-acetylserotonin, and melatonin on spontaneous contraction of isolated rat intestine. J Pineal Res 1986; 3: 41-54.
26. Harlow HJ, Weekly BL. Effect of melatonin on the force of spontaneous contractions of in vitro rat small and large intestine. J Pineal Res 1986; 3: 277-284.
27. Kachi T, Suzuki T, Yanagisawa M, Kimura N, Irie T. Pineal-gut relations. Hirosaki Med J 1999; 51: S209-S213.
28. Drago F, Macauda S, Salehi S. Small doses of melatonin increase intestinal motility in rats. Dig Dis Sci 2002; 47: 1969-1974.
29. Petrie KA, Dawson G, Thompson L, Brook R. A double-blind trial of melatonin as a treatment for jet lag in international cabin crew. Biol Psychiatri 1993; 33: 526-530.
30. Blask DE. Melatonin in oncology. In Melatonin Biosynthesis, Physiological Effects and Clinical Applications, Yu H-S, Reiter RJ (eds). Boca Raton, CRC Press, 1993, pp. 447-477.
31. Conti A, Maestroni GJM. The clinical neuroimmunotherapeutic role of melatonin in oncology. J Pineal Res 1995; 19: 103-110.
32. Reiter RJ, Carneiro RC, Oh CS. Melatonin in relation to cellular antioxidative defence mechanisms. Horm Metab Res 1997; 29: 363-372.
33. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ. Melatonin: A potent endogenous, hydroxyl radical scavenger. Endocr J 1993; 1: 57-60.
34. Reiter RJ. Antioxidant actions of melatonin. Adv Pharmachol 1997; 38: 103-117.
35. Kawashima K, Miwa Y, Fujimoto K, Oohata H, Nishino H, Koike H. Antihypertensive action of melatonin in the spontaneously hypertensive rat. Clin Exp Theory Pract 1987, A9: 1121-1131.
36. Voorsdouw BCG, Euser R, Verdonk RER, et al. Melatonin and melatonin-progestine combinations alter pituitary-ovarian function in women and can inhibit ovulation. J Clin Endocrinol Metab 1992; 74: 108-117.
37. Bruls E, Crasson M, Van Reeth O, Legros JJ. Melatonin. II. Physiological and therapeutic effects. Rev Med Liege 2000; 55: 862-870.
38. Reiter RJ, Cabrera J, Sainz Rm, Mayo JC, Manchester LC, Tan DX. Melatonin as a pharmachological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and parkinsonism. Ann N Y Acad Sci 1999; 890: 471-485.
39. Cardinalli DP, Brusco L, Liberczuk C, Furio AM. The use of melatonin in Alzheimer's disease. Neuroendocrinol Lett 2002; 1: 20-23.
40. No authors listed. Melatonin: interesting but not miraculous. Prescrire Int 1998; 38: 180-187.
41. Dimaline R, Carter N, Barnes S. Evidence for reflex adrenergic inhibition of acid secretion in conscious rats. Am J Physiol 1986; 251: G615-G618.
42. Green T, Dimaline R, Peikin S, Dockray GJ. Action of cholecystokinin antagonist L364,718 on gastric emptying in the rat. Am J Physiol 1988; 255: G685-G689.
43. Debas HT, Farooqu O, Grassman MI. Inhibition of gastric emptying is a physiological action of cholecystokinin. Gastroenterology 1975; 68: 1211-1217.
44. Mazelin L, Theodorou V, More J, Fioramonti J, Bueno L. Protective role of vagal afferents in experimentally-induced colitis in rats. J Auton Nerv Syst 1998; 73: 38-45.
45. Forster ER, Green T, Elliot M, Dockray GJ. Gastric emptying in rats: role of afferent neurons and cholecystokinin. Am J Physiol 1990; 258: G552-G556.
46. Paul MA, Gray G, Kenny G, Pigeau RA. Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance. Aviat Space Environ Med 2003; 74: 1263-1270.
47. Turk J. Melatonin supplementation for severe and intractable sleep disturbance in young people with genetically determined developmental disabilities: short review and commentary. J Med Genet 2003; 40: 793-796.
48. Bubenik GA, Blask DE, Brown GM, et al. Prospects of the clinical utilization of melatonin. Biol Signals Recept 1998; 7: 195-219.
49. Birketvedt GS, Florholmen J, Sundsfjord J, et al. Behavioral and neuroendocrine characteristics of the night-eating syndrome. JAMA 1999; 282:657-663.
50. Bubenik GA, Dhanvantari S. Influence of serotonin and melatonin on some parameters of gastrointestinal activity. J Pineal Res 1989; 7: 333-344.
51. Barajas-Lopez C, Peres AL, Espinosa-Luna R, Reyes-Vazquez C, Prieto-Gomez B. Melatonin modulates cholinergic transmission by blocking nicotinic channels in the guinea-pig submucous plexus. Eur J Pharmacol 1996; 312: 319-325.
52. Bubenik GA, Ball RO, Pang SF. The effect of food deprivation on brain and gastrointestinal tissue levels of tryptophan, serotonin, 5-hydroxyindoleacetic acid, and melatonin. J Pineal Res 1992; 12: 7-16.
53. Fioretti MC, Barzi F, Martini L. Affinity of melatonin for serotonin receptors in the isolated rat stomach. Riv Farmacol Terap 1972; 3: 383-391.
54. Tache Y, Stevens RL, Ishikawa T. Central nervous system action of TRH influences gastrointestinal function and ulceration. Ann NY Acad Sci 1989; 553: 269-285.
55. Ayles HL, Ball RO, Friendship RM, Bubenik GA. The effect of graded levels of melatonin on performance and gastric ulcers in pigs. Can J Anim Sci 1996; 76: 607-611.
56. Cho HC, Pang SF, Chen BW, Pfeifer CJ. Modulating action of melatonin on serotonin-induced aggravation of ethanol ulceration and changes of mucosal blood flow in rat stomach. J Pineal Res 1989; 6: 89-97.
57. Konturek PC, Konturek SC, Brzozowski T, et al. Gastroprotective activity of melatonin and its precursor, L-tryptophan, against stress-induced and ischemia-induced lesions is mediated by scavenge of oxygen radicals. Scand J Gastroenterol 1997; 32: 433-438.
58. Konturek PC, Konturek S, Majka J, Zembala M, Hahn EG. Melatonin affords protection against gastric lesions induced by ischemia-reperfusion possibly due to its antioxidant and mucosal microcirculatory effects. Eur J Pharmacol 1997; 122: 73-77.
59. Raybould HE, Glatzle J, Robin C, et al. Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying. Am J Physiol Gastrointest Liver Physiol 2003; 284: G367-G372.
60. Forster ER, Green T, Elliot M, Bremner A, Dockray GJ. Gastric emptying in rats: role of afferent neurons and cholecystokinin. Am J Physiol 1990; 258: G552-G556.
61. Glatzle J, Wang Y, Adelson DW, et al. Chylomicron components activate duodenal vagal afferents via a cholecystokinin A receptor-mediated pathway to inhibit gastric motor function in the rat. J Physiol 2003; 550: 657-664.
62. Benouali-Pellissier S. Melatonin is involved in cholecystokinin-induced changes of ileal motility in rats. J Pineal Res 1994; 17: 79-85.
63. Brzozowska I, Konturek PC, Brozozowski T, et al. Role of prostaglandins, nitric oxide, sensory nerves and gastrin in acceleration of ulcer healing by melatonin and its precursor, L-tryptophan. J Pineal Res 2002; 32: 149-162.
64. Jaworek J, Nawrot K, Konturek SJ, Leja-Szpak A, Thor P, Pawlik WW. Melatonin and its precursor, L-tryptophan: influence on pancreatic amylase secretion in vivo and in vitro. J Pineal Res 2004; 36: 155-164.
65. Bubenik GA. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 2002; 47: 2336-2348.